**Appendix**


**61**

**Author details**

provided the original work is properly cited.

Naresh Kumar Monigari\* and Anoop Agarwal

\*Address all correspondence to: medico.ktya@gmail.com

CARE Hospitals, Hyderabad, India

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium,

*Transcatheter Aortic Valve Replacement: Clinical Indications and Outcomes*

*DOI: http://dx.doi.org/10.5772/intechopen.84909*

RELM reduced leaflet motion

SOV sinus of valsalva

CABG coronary artery bypass graft BAV balloon aortic valvuloplasty THV transcutaneous heart valve PVT percutaneous valve technologies

TVT transcatheter valve therapy TEE trans oesophageal echo

VHD valve hemodynamic deterioration SVD structural valve degeneration

TAVR transcatheter aortic valve replacement HALT hypo attenuated leaflet thickening

COPD chronic obstructive pulmonary disease

PARTNER placement of aortic transcatheter valve trial

NOTION Nordic aortic valve intervention trial

SOURCE Sapien aortic bioprosthesis European Outcome Registry

SURTAVI surgical replacement and transcatheter aortic valve implantation

*Transcatheter Aortic Valve Replacement: Clinical Indications and Outcomes DOI: http://dx.doi.org/10.5772/intechopen.84909*

